In a recent article for PharmaBoardroom, Objective Capital's David Crean took a look at the state of US innovation today and its long term sustainability. See below for data on the share of US executives who see innovation as a top priority post-COVID, Global Public Equity Issuance for the Biopharmaceutical Sector, Biotech Global IPO Volume by Region, the amount raised by healthcare venture capital funds, M&A activity by sector, global biopharma M&A volume, pharma M&A activity by niche, and the biopharmaceutical sector's overall contribution to the US economy.
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
Made with Visme Infographic Maker
